PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cells from the eye are inkjet printed for the first time

2013-12-18
(Press-News.org) Contact information: Michael Bishop
michael.bishop@iop.org
01-179-301-032
Institute of Physics
Cells from the eye are inkjet printed for the first time A group of researchers from the UK have used inkjet printing technology to successfully print cells taken from the eye for the very first time.

The breakthrough, which has been detailed in a paper published today, 18 December, in IOP Publishing's journal Biofabrication, could lead to the production of artificial tissue grafts made from the variety of cells found in the human retina and may aid in the search to cure blindness.

At the moment the results are preliminary and provide proof-of-principle that an inkjet printer can be used to print two types of cells from the retina of adult rats―ganglion cells and glial cells. This is the first time the technology has been used successfully to print mature central nervous system cells and the results showed that printed cells remained healthy and retained their ability to survive and grow in culture.

Co-authors of the study Professor Keith Martin and Dr Barbara Lorber, from the John van Geest Centre for Brain Repair, University of Cambridge, said: "The loss of nerve cells in the retina is a feature of many blinding eye diseases. The retina is an exquisitely organised structure where the precise arrangement of cells in relation to one another is critical for effective visual function".

"Our study has shown, for the first time, that cells derived from the mature central nervous system, the eye, can be printed using a piezoelectric inkjet printer. Although our results are preliminary and much more work is still required, the aim is to develop this technology for use in retinal repair in the future."

The ability to arrange cells into highly defined patterns and structures has recently elevated the use of 3D printing in the biomedical sciences to create cell-based structures for use in regenerative medicine.

In their study, the researchers used a piezoelectric inkjet printer device that ejected the cells through a sub-millimetre diameter nozzle when a specific electrical pulse was applied. They also used high speed video technology to record the printing process with high resolution and optimised their procedures accordingly.

"In order for a fluid to print well from an inkjet print head, its properties, such as viscosity and surface tension, need to conform to a fairly narrow range of values. Adding cells to the fluid complicates its properties significantly," commented Dr Wen-Kai Hsiao, another member of the team based at the Inkjet Research Centre in Cambridge.

Once printed, a number of tests were performed on each type of cell to see how many of the cells survived the process and how it affected their ability to survive and grow.

The cells derived from the retina of the rats were retinal ganglion cells, which transmit information from the eye to certain parts of the brain, and glial cells, which provide support and protection for neurons.

"We plan to extend this study to print other cells of the retina and to investigate if light-sensitive photoreceptors can be successfully printed using inkjet technology. In addition, we would like to further develop our printing process to be suitable for commercial, multi-nozzle print heads," Professor Martin concluded.

### Notes to Editors

The research was undertaken by Dr. Barbara Lorber, also at the John van Geest Centre for Brain Repair, in collaboration with Dr. Wen-Kai Hsiao and Prof. Ian Hutchings from the Inkjet Research Centre, University of Cambridge. The work was funded by Fight for Sight, the van Geest Foundation and the EPSRC.

From Wednesday 18 December, the paper can be downloaded from http://iopscience.iop.org/1758-5090/6/1/015001/article

Contact

1. For further information, a full draft of the journal paper or contact with one of the researchers, contact IOP Press Officer, Michael Bishop:
Tel: 0117 930 1032
E-mail: michael.bishop@iop.org

For more information on how to use the embargoed material above, please refer to our embargo policy.

IOP Publishing Journalist Area

2. The IOP Publishing Journalist Area gives journalists access to embargoed press releases, advanced copies of papers, supplementary images and videos. In addition to this, a weekly news digest is uploaded into the Journalist Area every Friday, highlighting a selection of newsworthy papers set to be published in the following week.

Login details also give free access to IOPscience, IOP Publishing's journal platform.

To apply for a free subscription to this service, please email Michael Bishop, IOP Press Officer, michael.bishop@iop.org, with your name, organisation, address and a preferred username.

Adult rat retinal ganglion cells and glia can be printed by piezoelectric inkjet printing

3. The published version of the paper 'Adult rat ganglion cells and glia can be printed by piezoelectric inkjet printer' Barbara Lorber et al 2014 Biofabrication 6 015001 will be freely available online from Wednesday 18 December. It will be available at http://iopscience.iop.org/1758-5090/6/1/015001/article

Biofabrication

4. A journal focusing on using cells, proteins, biomaterials and/or other bioactive elements as building blocks to fabricate advanced biological models, medical therapeutic products and non-medical biological systems.

IOP Publishing

5. IOP Publishing provides a range of journals, magazines, websites and services that enable researchers and research organisations to reach the widest possible audience for their research.

We combine the culture of a learned society with global reach and highly efficient and effective publishing systems and processes. With offices in the UK, US, Germany, China and Japan, and staff in many other locations including Mexico and Russia, we serve researchers in the physical and related sciences in all parts of the world.

IOP Publishing is a wholly owned subsidiary of the Institute of Physics. The Institute is a leading scientific society promoting physics and bringing physicists together for the benefit of all. Any profits generated by IOP Publishing are used by the Institute to support science and scientists in both the developed and developing world. Go to ioppublishing.org.

The Institute of Physics

6. The Institute of Physics is a leading scientific society. We are a charitable organisation with a worldwide membership of more than 50,000, working together to advance physics education, research and application. We engage with policymakers and the general public to develop awareness and understanding of the value of physics and, through IOP Publishing, we are world leaders in professional scientific communications. Go to http://www.iop.org


ELSE PRESS RELEASES FROM THIS DATE:

Freezing semen doubles the chances of fatherhood for men after treatment for Hodgkin lymphoma

2013-12-18
Freezing semen doubles the chances of fatherhood for men after treatment for Hodgkin lymphoma Men with Hodgkin lymphoma who want to become fathers after their cancer treatment have greatly increased chances of doing so if they have frozen and stored ...

Sunlight adaptation region of Neanderthal genome found in up to 65 percent of modern East Asian population

2013-12-18
Sunlight adaptation region of Neanderthal genome found in up to 65 percent of modern East Asian population Recent highlights in the journal Molecular Biology and Evolution With the Neanderthal genome now published, for the first ...

A roly-poly pika gathers much moss

2013-12-18
A roly-poly pika gathers much moss High-fiber salad bar may help lagomorphs survive climate change SALT LAKE CITY, Dec. 18, 2013 – In some mountain ranges, Earth's warming climate is driving rabbit relatives known as pikas to higher elevations or wiping them out. But ...

Lower Rio Grande Basin study shows shortfall in future water supply

2013-12-18
Lower Rio Grande Basin study shows shortfall in future water supply Reclamation study finds shortfall of 678,522 acre-feet of water per year will be needed in basin in 2060 due to increased demand and climate change WASHINGTON - Bureau of Reclamation Commissioner Michael ...

Performance-enhancing drug use more prevalent than Type 1 diabetes or HIV infection

2013-12-18
Performance-enhancing drug use more prevalent than Type 1 diabetes or HIV infection Endocrine Society unveils scientific statement on the health consequences of performance-enhancing drugs Chevy Chase, MD— A new Scientific Statement issued today by The Endocrine Society ...

MU researchers develop advanced 3-dimensional 'force microscope'

2013-12-18
MU researchers develop advanced 3-dimensional 'force microscope' Innovation could lead to faster drug therapies and increased understanding of proteins on the microscopic level COLUMBIA, Mo. – Membrane proteins are the "gatekeepers" that allow information ...

Bonobos stay young longer

2013-12-18
Bonobos stay young longer Contrary to humans and chimpanzees bonobos retain elevated thyroid hormones well into adulthood This news release is available in German. Despite the fact that chimpanzees and bonobos share similar starting conditions ...

Exposing the roots of the lithium battery problem

2013-12-18
Exposing the roots of the lithium battery problem Berkeley Lab researchers find dendrite problem starts below the surface The lithium-ion batteries that power our laptops, smartphones and electric vehicles could have significantly higher energy density ...

NASA satellites get double coverage on newborn Tropical Cyclone Amara

2013-12-18
NASA satellites get double coverage on newborn Tropical Cyclone Amara System 93S strengthened into the third tropical depression of the Southern Indian Ocean cyclone season, which quickly became a tropical storm named Amara. NASA's TRMM and Aqua satellites flew overhead ...

Study finds known lung cancer oncogenes ALK and ROS1 also drive colorectal cancer

2013-12-18
Study finds known lung cancer oncogenes ALK and ROS1 also drive colorectal cancer Genetically targeted drugs in use for lung cancer may have colorectal cancer application, as well A University of Colorado Cancer Center study published online ahead of print in the ...

LAST 30 PRESS RELEASES:

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

[Press-News.org] Cells from the eye are inkjet printed for the first time